Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current tuberculosis vaccine development.

D B Young1

  • 1Department of Infectious Diseases and Microbiology, Imperial College School of Medicine, London, London W2 1PG, United Kingdom. d.young@ic.ac.uk.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|June 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the breadth and complexity of bovine viral diarrhea (BVDV) populations circulating in 34 persistently infected cattle generated in one outbreak.

Virology·2015
Same author

The 65kDa antigen of mycobacteria-a common bacterial protein?

Immunology today·2014
Same author

The ongoing challenge of latent tuberculosis.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2014
Same author

The development and validation of The Inquiry Science Observation Coding Sheet.

Evaluation and program planning·2008
Same author

Effect of skin testing and segregation on the prevalence of bovine tuberculosis, and molecular typing of Mycobacterium bovis, in Ethiopia.

The Veterinary record·2007
Same author

Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2006
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Low Post-Treatment Recurrence After a Shortened All-oral Regimen for Pulmonary Rifampicin- or Multidrug-Resistant Tuberculosis in Individuals without Prior Second-Line Drug Exposure in Kazakhstan.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Sepsis Diagnostic Excellence and its Association with Mortality in Adults with Potential Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

10-Year Trends in Attributable and Contributable Mortality of Culture-Positive Invasive Aspergillosis in Patients with Hematologic Malignancies: Have We Reached the "Ceiling Efficacy Effect" of Modern Antifungals?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Virologic Outcomes After LA ART Initiation with and without Viremia in Two Large U.S. Clinic Cohorts.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Andes Virus Exposure and Nosocomial Transmission Events to Healthcare Personnel: A Systematic Review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

New Mycobacterium tuberculosis genome information enables novel vaccine development. Research explores whole-cell and subunit approaches, addressing key questions in tuberculosis vaccine design and application.

Area of Science:

  • Genomics
  • Vaccinology
  • Microbiology

Background:

  • The complete genome sequence of Mycobacterium tuberculosis provides a foundation for developing new vaccine candidates.
  • Current research focuses on innovative strategies for tuberculosis prevention.

Purpose of the Study:

  • To review fundamental questions in the rational design of novel tuberculosis vaccines.
  • To discuss preclinical testing and future applications of new vaccine candidates.

Main Methods:

  • Leveraging information from the complete Mycobacterium tuberculosis genome sequence.
  • Investigating whole-cell live attenuated mycobacterial vaccines.
  • Exploring subunit vaccination procedures using individual antigens.

Main Results:

Related Experiment Videos

  • The study reviews current strategies and fundamental questions in tuberculosis vaccine development.
  • It highlights the potential of genomic information for creating new vaccine candidates.

Conclusions:

  • Complete genome sequencing of Mycobacterium tuberculosis is crucial for advancing vaccine development.
  • Further research into rational design, preclinical testing, and application is essential for effective tuberculosis vaccines.